(PLRX) - FDA

(PLRX) – FDA

Feb 5, 2024 05:50 AM Pliant Therapeutics (PLRX) Reports Positive Safety and Exploratory Efficacy Data from the INTEGRIS-PSC Phase 2a Trial of Bexotegrast
Sep 26, 2023 07:48 AM Pliant Therapeutics (PLRX) Climbs 27% Following Positive Safety and Exploratory Efficacy Data from Phase 2a INTEGRIS-PSC Trial of Bexotegrast
Sep 26, 2023 07:30 AM
May 24, 2023 08:04 AM
May 1, 2023 05:22 AM
Mar 13, 2023 08:02 AM
Feb 2, 2023 08:03 AM
Jan 23, 2023 07:06 AM
Jan 23, 2023 05:44 AM
Dec 15, 2022 08:08 AM
Sep 1, 2022 08:04 AM
Jul 21, 2022 08:00 AM
Jul 11, 2022 05:42 AM
Jun 24, 2022 08:01 AM
Jun 22, 2022 08:01 AM
May 3, 2022 08:02 AM
Feb 28, 2022 08:00 AM
Feb 24, 2022 05:41 PM
Jan 11, 2022 08:04 AM
Sep 7, 2021 07:02 AM
Mar 16, 2021 08:05 AM